Literature DB >> 30888254

Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.

Heather Burrell Ward1,2, Brian S Barnett2,3, Joji Suzuki2,4.   

Abstract

Background: Patients taking methadone for opioid use disorder may desire transition to buprenorphine for a number of reasons. However, the current recommended approach for this transition generally takes weeks to months as an outpatient, causing considerable discomfort to the patient and a heightened risk of relapse during the transition period. Case: We describe the case of a patient on methadone maintenance who was rapidly transitioned to buprenorphine because of her desire to not return to her methadone clinic. In order to rapidly transition the patient from methadone to buprenorphine, naltrexone was administered to precipitate acute opioid withdrawal, which was followed soon after by buprenorphine induction. Discussion: Rapid transition from methadone maintenance to buprenorphine can be accomplished in inpatients by precipitating acute withdrawal with naltrexone, providing an effective alternative for patients who cannot tolerate the typical protracted methadone taper required prior to buprenorphine induction as an outpatient.

Entities:  

Keywords:  Methadone; buprenorphine; naltrexone; opioid withdrawal

Year:  2019        PMID: 30888254     DOI: 10.1080/08897077.2019.1573776

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  5 in total

1.  Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis.

Authors:  Dana Button; Jennifer Hartley; Jonathan Robbins; Ximena A Levander; Natashia J Smith; Honora Englander
Journal:  J Addict Med       Date:  2022 Mar-Apr 01       Impact factor: 3.702

2.  Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting.

Authors:  Joao P De Aquino; Christopher Fairgrieve; Sukhpreet Klaire; Gabriela Garcia-Vassallo
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 4.647

Review 3.  The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.

Authors:  Joao P De Aquino; Suprit Parida; Mehmet Sofuoglu
Journal:  Clin Drug Investig       Date:  2021-04-05       Impact factor: 2.859

Review 4.  Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.

Authors:  Lauren A Spreen; Emma N Dittmar; Kyle C Quirk; Michael A Smith
Journal:  Pharmacotherapy       Date:  2022-03-25       Impact factor: 6.251

5.  Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report.

Authors:  Laura M Szczesniak; Vincent J Calleo; Ross W Sullivan
Journal:  Harm Reduct J       Date:  2020-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.